Can I Take Zinc With Avodart (Dutasteride)?

Why This Question Comes Up

Dutasteride (brand name Avodart) is a dual 5-alpha reductase inhibitor approved by the FDA for benign prostatic hyperplasia (BPH) and used off-label for androgenetic alopecia [1]. Zinc is one of the most popular over-the-counter supplements among men, taken for immune support, testosterone optimization, and prostate health. The overlap is obvious: both compounds interact with androgen metabolism.

The Pharmacodynamic Overlap

Zinc does not change how the liver absorbs or clears dutasteride. No cytochrome P450 competition has been identified between the two. The interaction is pharmacodynamic, meaning both agents act on a shared biological target rather than altering each other's blood levels [3].

Why Prescribers Rarely Flag It

Because no case reports of adverse outcomes from this combination appear in the FDA Adverse Event Reporting System (FAERS) or in major drug interaction databases like Lexicomp, most clinicians do not warn patients about it. That does not mean the combination is risk-free. It means the risk is low enough that it has not generated safety signals at typical supplement doses.

How Dutasteride Works

Dutasteride blocks both type I and type II isoforms of the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). The result is a roughly 90% reduction in serum DHT within two weeks of starting 0.5 mg daily [1]. This suppression is what shrinks the prostate in BPH and slows miniaturization of hair follicles in pattern hair loss.

The CombAT Trial in Context

In the Combination of Avodart and Tamsulosin (CombAT) trial (N=4,844), dutasteride 0.5 mg reduced prostate volume by 28% at four years and cut the relative risk of acute urinary retention or BPH-related surgery by 66% compared with tamsulosin alone [5]. These numbers matter because they show how potent dutasteride's 5-alpha reductase blockade already is. Any additional inhibition from zinc is minor by comparison.

Dutasteride's Long Half-Life

Dutasteride has a terminal half-life of approximately five weeks at steady state [1]. That means even after you stop taking it, the drug stays active for months. Any additive pharmacodynamic effect from zinc is layered on top of a drug that is already doing the vast majority of the work.

How Zinc Interacts With 5-Alpha Reductase

A 1988 study in the British Journal of Dermatology by Stamatiadis and colleagues showed that zinc sulfate inhibited 5-alpha reductase activity in human skin homogenates in vitro [3]. The inhibition was concentration-dependent, with meaningful effects seen at 3 to 9 mmol/L. For context, serum zinc concentrations in humans typically range from 0.01 to 0.02 mmol/L, roughly 150 to 450 times lower than the concentrations tested in the lab.

In Vitro vs. In Vivo

This gap is the reason most clinicians consider the interaction clinically insignificant at standard supplement doses. A 30 mg zinc gluconate tablet does not produce tissue concentrations anywhere near the levels that inhibited 5-alpha reductase in a petri dish. The enzyme inhibition is real in a laboratory setting, but the dose required to replicate it in a living person would likely cause toxicity before producing a measurable DHT effect.

Prostate Tissue Concentrations

Zinc does concentrate in prostate tissue at levels higher than in serum. Healthy prostate tissue contains 10 to 15 times more zinc than other soft tissues [6]. Some researchers have hypothesized that this local accumulation could produce enough 5-alpha reductase inhibition to matter clinically, but no randomized controlled trial has tested whether oral zinc supplementation adds meaningful DHT suppression on top of dutasteride therapy.

The Real Risk: Copper Depletion

The more clinically relevant concern with long-term zinc supplementation is not the interaction with dutasteride itself. It is zinc-induced copper deficiency.

How Zinc Depletes Copper

Zinc and copper compete for absorption through the same intestinal transporter, divalent metal transporter 1 (DMT1), and through metallothionein binding in enterocytes. When zinc intake is chronically elevated, intestinal cells produce excess metallothionein, which preferentially binds copper and traps it inside cells that are later shed into the gut lumen [4]. The copper never reaches the bloodstream.

Clinical Consequences

Fosmire's 1990 review in the American Journal of Clinical Nutrition documented that intakes above 50 mg/day of elemental zinc for extended periods produced copper deficiency, manifesting as sideroblastic anemia, neutropenia, and neurological deterioration [4]. A case series by Nations and colleagues in Neurology (2008) described patients who developed myelopathy and peripheral neuropathy from chronic zinc supplementation, all of whom had profoundly low serum copper levels [7].

Why This Matters for Dutasteride Users

Men taking dutasteride for BPH tend to be over 50. Men taking it off-label for hair loss tend to be on it for years. Both groups are likely to also take zinc long-term. The combination of extended duration plus a population that may already have marginal copper status (due to age, diet, or proton pump inhibitor use) makes copper monitoring a practical necessity, not a theoretical nicety.

Dose and Timing Recommendations

How Much Zinc Is Appropriate

The National Institutes of Health Office of Dietary Supplements sets the recommended dietary allowance (RDA) for adult men at 11 mg of elemental zinc per day and the tolerable upper intake level (UL) at 40 mg per day [2]. For men combining zinc with dutasteride, staying between 15 and 30 mg daily is a reasonable target. This range provides the immune and enzymatic support most people are looking for without pushing copper absorption into dangerous territory.

Dose Separation

There is no pharmacokinetic basis for strict dose separation, since zinc does not affect dutasteride absorption via CYP3A4 or P-glycoprotein. Still, taking the two at different times of day (separated by roughly two hours) reduces the chance of gastrointestinal discomfort that some people experience when taking zinc on an empty stomach alongside a lipophilic capsule like dutasteride.

Which Zinc Form to Choose

Zinc picolinate and zinc bisglycinate have higher bioavailability than zinc oxide [8]. If you are aiming for a specific elemental zinc dose, check the label carefully. A "50 mg zinc gluconate" tablet delivers only about 7 mg of elemental zinc. A "50 mg zinc picolinate" tablet delivers roughly 10 mg. The form matters for both efficacy and copper depletion risk.

Monitoring Protocol

Baseline Labs

Before starting zinc supplementation alongside dutasteride, a reasonable baseline panel includes serum zinc, serum copper, ceruloplasmin, and a complete blood count (CBC) with differential. The CBC catches early signs of copper-deficiency anemia (macrocytosis, neutropenia) before symptoms appear.

Ongoing Monitoring

For men taking 15 to 30 mg of elemental zinc daily, rechecking serum copper, ceruloplasmin, and CBC every 6 to 12 months is sufficient. If zinc intake exceeds 40 mg daily for any reason (including dietary sources like oysters, red meat, and fortified cereals), the interval should shorten to every 3 to 6 months.

When to Stop Zinc

Discontinue zinc supplementation and consult your prescriber if serum copper falls below 70 mcg/dL, if ceruloplasmin drops below 15 mg/dL, or if the CBC shows unexplained anemia or neutropenia. Copper repletion typically requires 2 mg of oral copper daily for 1 to 3 months, though severe cases may need intravenous copper [7].

Zinc, Testosterone, and DHT: Clarifying the Claims

The Prasad Study

A 1996 study by Prasad and colleagues in Nutrition reported that marginal zinc deficiency in young men (induced by restricting zinc intake to 5 mg/day for 20 weeks) reduced serum testosterone by approximately 75% [9]. Supplementing zinc back to adequate levels restored testosterone. This study is frequently cited in supplement marketing, but its clinical relevance to men who are already zinc-replete is minimal. If your zinc status is normal, adding more zinc does not raise testosterone further.

DHT Implications

Since dutasteride already suppresses DHT by roughly 90%, and zinc's in vivo 5-alpha reductase inhibition at supplement doses is negligible, the net effect of adding zinc on DHT levels in a dutasteride-treated patient is likely unmeasurable. The concern is theoretical. No clinical trial has shown that zinc supplementation causes symptomatic over-suppression of DHT in patients already on a 5-alpha reductase inhibitor.

What About Estradiol?

Some men worry that lower DHT from combined therapy could shift the testosterone-to-estradiol ratio. Dutasteride does increase serum testosterone by 10 to 20% (because less is being converted to DHT), and a small fraction of that additional testosterone is aromatized to estradiol [1]. Zinc at typical supplement doses is unlikely to shift this ratio further in a clinically meaningful way, but men experiencing gynecomastia or breast tenderness on dutasteride should report it regardless of supplement use.

What the Guidelines Say

The American Urological Association (AUA) 2021 guidelines on BPH management do not address zinc supplementation specifically [10]. The Endocrine Society's clinical practice guidelines on androgen therapy do not list zinc as a contraindication or a required co-supplement with 5-alpha reductase inhibitors. The absence of guidance reflects the absence of clinical trial data on this specific combination, not an implicit endorsement.

Natural Medicines Database Rating

The Natural Medicines Comprehensive Database rates the zinc and dutasteride interaction as having insufficient evidence to assign a severity rating. This is the most common classification for supplement-drug pairs that share a pharmacodynamic pathway but lack human outcome data.

Practical Interpretation

"No interaction listed" does not mean "no interaction exists." It means the interaction has not caused enough harm at population scale to generate a warning. For a drug with a five-week half-life and 90% DHT suppression, the pharmacodynamic contribution of a 25 mg zinc tablet is unlikely to be the variable that tips someone into adverse effects. Copper depletion remains the primary concern.

Special Populations

Men Over 65

Older men are more likely to have marginal copper status due to reduced dietary intake, polypharmacy (especially proton pump inhibitors, which impair mineral absorption), and age-related changes in intestinal absorption [4]. Copper monitoring is more important in this group, and starting zinc at the lower end of the range (15 mg/day) is prudent.

Men With Liver Disease

Dutasteride is extensively metabolized by CYP3A4 in the liver. The FDA labeling notes that dutasteride has not been studied in patients with hepatic impairment, and its clearance may be reduced in this population [1]. Zinc metabolism is also altered in liver disease, with many cirrhotic patients already zinc-deficient. This population needs individualized dosing and closer monitoring, not a blanket prohibition.

Men Using Finasteride Instead

Finasteride inhibits only the type II isoform of 5-alpha reductase and produces roughly 70% DHT suppression compared with dutasteride's 90% [11]. The same zinc considerations apply, but the pharmacodynamic overlap is somewhat smaller. The copper depletion risk is identical regardless of which 5-alpha reductase inhibitor is used.

What to Do If You Are Already Taking Both

If you have been taking zinc alongside dutasteride without any monitoring, do not stop abruptly. Instead, schedule a lab draw for serum copper, ceruloplasmin, CBC, and serum zinc. If all values are normal, continue at your current dose and recheck in 6 to 12 months. If copper is low or borderline, reduce zinc to 15 mg/day or less and begin copper repletion under medical supervision.

Confirm your elemental zinc intake by reading the supplement facts panel, not just the front label. Many men discover they are taking 50 mg of a zinc salt that delivers only 10 to 15 mg of elemental zinc, which is well within safe limits.